Cryoablation, Sarcoma
Conditions
Brief summary
This is a single-center, open, retrospective clinical study of patients with metastatic/surgically unresectable bone and soft tissue sarcoma undergoing cryoablation of selected tumor lesions. All eligible patients were enrolled. Basic data and treatment methods of these patients were collected, and efficacy and safety were evaluated.
Detailed description
This is a single-center, open, retrospective clinical study of patients with metastatic/surgically unresectable bone and soft tissue sarcoma undergoing cryoablation of selected tumor lesions. Clinical data of eligible patients were scheduled to be retrospectively collected from December 2016 to February 28, 2022. All patients eligible for inclusion. Basic data and treatment methods of these patients were collected, and efficacy and safety were evaluated.
Interventions
PROCEDURECryoablation
Cryoablation of selected tumor lesions
Sponsors
Henan Cancer Hospital
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
No age restriction, male or female. The pathological diagnosis was a subtype of bone and soft tissue sarcoma. The clinical stage was determined to be metastatic or locally unresectable bone and soft tissue sarcoma. At least one cryoablation of tumor lesions was performed in our hospital. Target lesions can be evaluated according to the efficacy evaluation criteria for solid tumors (RECIST; Version 1.1) Measure diameter changes. Follow-up data were complete.
Exclusion criteria
Not applicable.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Survival rates | 12 months after surgery | 1-year survival rate |
| There was no local recurrence survival rate | 12 months after surgery | The 1-year survival rate without local recurrence |
Countries
China
Contacts
Primary ContactWang Jiaqiang, Dr
Backup ContactTian Zhichao, Dr
Outcome results
None listed